Is transurethral needle ablation of prostate out of fashion? Outcomes of single session office-based transurethral needle ablation of prostate in patients with symptomatic benign prostatic hyperplasia.
Yu Xi Terence LawWei Jing Kelven ChenLiang ShenWei Jin ChuaPublished in: Investigative and clinical urology (2019)
Our study is the first to investigate the use of a single-setting office-based TUNA requiring minimal sedation in the Asian community. Complication rates were low in our series, with no associated mortality. When applied to selected patients, TUNA is an effective and reasonably safe alternative for the treatment of symptomatic BPH.
Keyphrases
- benign prostatic hyperplasia
- lower urinary tract symptoms
- end stage renal disease
- ultrasound guided
- newly diagnosed
- chronic kidney disease
- ejection fraction
- healthcare
- mental health
- prostate cancer
- cardiovascular events
- risk factors
- type diabetes
- cardiovascular disease
- intensive care unit
- coronary artery disease
- transcranial direct current stimulation
- combination therapy
- catheter ablation
- patient reported outcomes
- metabolic syndrome
- mechanical ventilation
- working memory
- acute respiratory distress syndrome
- replacement therapy
- patient reported
- weight loss